Skip to content

Leadership in Infection Control

Leadership in Infection Control - LEAD-IC

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00013016
Enrollment
30
Registered
2017-09-22
Start date
2018-01-24
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prevention of nosocomial infections R65 A04.7

Interventions

Group 1: Structured multimodal infection control training of medical directors or their deputies in 2018. Data of arm 1 will be compared before (2017 data) and after (2018 data) Intervention
additionally, 2018 data (after Intervention) will be compared with 2018 data of arm 2 (before Intervention). Group 2: Structured multimodal infection control training of medical directors or their dep

Sponsors

Institut für Hygiene und UmweltmedizinCharité-Universitätsmedizin Berlin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Participation of the hospital for at least 18 months in the nosocomial infection surveillance system ("KISS") modules hand-KISS, MRSA-KISS (Surveillance of Methicillin-Resistant Staphylococcus aureus) and CDAD-KISS (Surveillance of Clostridium difficile associated diarrhea). Approval of the hospital management to participate. Participation by the Medical Director or his deputy.

Exclusion criteria

Exclusion criteria: Participation of the hospital in a similar study.

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the incidence (cases/ 1000 patients per year) and the incidence-density (cases/1000 patient days per year) of hospital-acquired blood stream infections (HA-BSI) on hospital level for 2017, 2018 and 2019. For this endpoint, blood cultures from day 3 after hospital admission are taken into account. Data are collected by the national nosocomial surveillance System.

Secondary

MeasureTime frame
Secondary endpoints for 2017, 2018 and 2019 are (i) the incidence/ incidence density of HA-BSI with resistant pathogens, (ii) the incidence/ incidence density of hospital-acquired clostridium difficile infections (CDI), and (iii) the consumption of alcohol-based hand rubs. All escondary endpoints are analyzed on hospital Level. Data are collected by the national nosocomial surveillance system.

Countries

Germany

Contacts

Public ContactCornelius Remschmidt

Institut für Hygiene und Umweltmedizin, Charité - Universitätsmedizin Berlin

cornelius.remschmidt@charite.de030 450 577 609

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026